Key predictors of peritonitis in ovarian cancer hospitalizations: Insights for early intervention.

S Srijani Thannir (The Brooklyn Hospital Center, Brooklyn, NY) J Jayalekshmi Jayakumar (3The Brooklyn Hospital Center, Internal Medicine, Brooklyn, United States) N Nikhil Vojjala (2Trinity Health Oakland/Wayne State University School of Medicine, Pontiac, United States) S Siddharth Karipineni (The Brooklyn hospital center, Brooklyn, New York, United States) P Pooja Bakshi (The Brooklyn Hospital Center, Brooklyn, NY) L Liannette Padilla Martinez (The Brooklyn Hospital Center, Brooklyn, NY) D Davin Turku (The Brooklyn Hospital Center, Brooklyn, NY) B Bansi Trambadia (The Brooklyn Hospital Center, Brooklyn, NY) K Khalimullah Quadri (New York Cancer and Blood Specialists, Brooklyn, NY)

Abstract

e17603 Background: Malignant ascites is a common complication of advanced ovarian cancer (OC) due to peritoneal metastasis, occurring in over one-third of patients at initial diagnosis and in nearly all patients with recurrent disease. It significantly impacts both quality of life and prognosis, with recurrent episodes increasing the risk of complications, including peritonitis, which affects approximately 10% of patients with malignant ascites. The aim of this study is to examine the predictors of peritonitis development during OC hospitalizations. Methods: This cross-sectional study utilized data from the National Inpatient Sample database (2016-2020). Adult hospitalizations with OC were included, and variables were identified using ICD-10 codes. Chi-square test was used to compare groups and identify predictors of peritonitis. STATA MP 17.0 was used for analysis, accounting for the complex design of the dataset. Statistical significance was set at p < 0.05. Results: 298,084 OC hospitalizations were identified, of which, 7.08% developed peritonitis. Patients with peritonitis were slightly younger than those without (mean age: 62.40 years vs 63.34 years). 70% of OC patients who developed peritonitis were Caucasian, 10% were African American, and 10% were Hispanic (p = 0.09). Geographically, 34% of peritonitis cases were from the South, 25% from the West, 21% from the Midwest, and 19% from the Northeast (p < 0.001). Patients with peritonitis were found to have longer hospital stays (mean length of stay: 8.41 days vs 5.49 days) and higher hospital charges (mean charges: $113,432 vs $64,262.48). Chi-square analysis identified post-laparotomy state, chemotherapy, sepsis, neutropenia and obesity as significant predictors of peritonitis in OC hospitalizations (Table). Conclusions: Peritonitis is a significant complication in OC hospitalizations, associated with worse outcomes and increased resource utilization. Our study identifies key predictors of peritonitis in OC hospitalizations. Targeting these predictors early in the disease course is critical to improving clinical outcomes. Chi-square analysis of the predictors of peritonitis in OC hospitalizations. Predictors Peritonitis Present (%) Peritonitis Absent (%) p-value Post-laparotomy 3.58 1.06 <0.001 Sepsis 15.79 7.51 <0.001 Chemotherapy 3.31 3.23 <0.001 Neutropenia 9.03 3.73 0.02 Obesity 16.59 13.09 <0.001

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

S

Srijani Thannir

The Brooklyn Hospital Center, Brooklyn, NY

J

Jayalekshmi Jayakumar

3The Brooklyn Hospital Center, Internal Medicine, Brooklyn, United States

N

Nikhil Vojjala

2Trinity Health Oakland/Wayne State University School of Medicine, Pontiac, United States

S

Siddharth Karipineni

The Brooklyn hospital center, Brooklyn, New York, United States

P

Pooja Bakshi

The Brooklyn Hospital Center, Brooklyn, NY

L

Liannette Padilla Martinez

The Brooklyn Hospital Center, Brooklyn, NY

D

Davin Turku

The Brooklyn Hospital Center, Brooklyn, NY

B

Bansi Trambadia

The Brooklyn Hospital Center, Brooklyn, NY

K

Khalimullah Quadri

New York Cancer and Blood Specialists, Brooklyn, NY